Trending News
News
News
Four COVID-19 Vaccines Teach T Cells To Fight SARS-CoV-2
Scientists have found that four COVID-19 vaccines prompt the body to make effective, long-lasting T cells against SARS-CoV-2. These T cells can recognize SARS-CoV-2 Variants of Concern, including Delta and Omicron.
News
Experimental Drug for Rare Type of ALS Begins Clinical Testing
An experimental drug called ION363 is being investigated in ALS patients in a global, Phase 3 clinical trial taking place in the United States, Europe and Asia.
News
Mutations Behind the Omicron Variant’s High Rate of Infection Identified
Researchers have identified the highly prevalent, specific mutations that are causing the Omicron variant’s high rate of infection.
News
Depression May Increase Susceptibility to COVID-19 Misinformation
Because depression may contribute to a negativity bias, a team of researchers examined whether people who experience depressive symptoms may be more receptive to misinformation related to COVID-19 vaccines.
News
Naturally Occurring Vesicles in the Blood of COVID-19 Patients Show Therapeutic Potential
Scientists have identified natural extracellular vesicles containing the ACE2 protein (evACE2) in the blood of COVID-19 patients that can block infection from broad strains of SARS-CoV-2 virus in preclinical studies.
News
COVID-19 Vaccination Does Not Impair Fertility
Research has shown that vaccination against COVID-19 does not affect fertility.
News
Immunotherapy Induced Peanut Allergy Remission in Some Children
A clinical trial funded by the National Institutes of Health has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth.
News
Epilepsy Study Further Bolsters Case for Newly Developed Gene Therapy
Research suggests how a newly developed gene therapy can treat Dravet syndrome, a severe form of epilepsy, and potentially prolong survival for people with the condition.
News
“Decoy” Protein Effective Against SARS-CoV-2 Variants in Mouse Study
According to a study, a drug treatment that acts as a decoy against SARS-CoV-2 was highly effective at preventing death and lung damage in humanized animal models of severe COVID-19 disease.
News
Omicron Recognized by T Cells From Previous Infection or Vaccination
Memory T cells generated after COVID-19 infection or mRNA vaccination are able to recognize the omicron variant of SARS-CoV-2.
Advertisement